Mitchell J. Weiss, MD, PhD
Disclosures: Ownership-Beam Therapeutics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Graphite Bio (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Forma Therapeutics (Relationship has ended) - 09/17/2021


Mitchell J. Weiss


January 9, 2020


Dr. Weiss is a physician-scientist who cares for pediatric patients with non-malignant blood diseases and performs related laboratory research. He received his MD and PhD degrees at the University of Pennsylvania School of Medicine, followed by training in pediatrics and pediatric hematology at Boston Children’s Hospital, The Dana Farber Cancer Institute and Harvard University.  For 15 years, he was a faculty member at The University of Pennsylvania School of Medicine (UPENN) and Children’s Hospital of Philadelphia (CHOP) where he rose to the rank of Professor of Pediatrics with Tenure. He was Director for the Pediatric Physician-Scientist Development Program at CHOP (2007-2011) and Associate Director for the Combined Degree and Physician Scholar Program at UPENN (2001-2014). He has mentored numerous fellows and young faculty, 5 of who received NIH K08 development awards. In 2014, he became Chairman of the Hematology Department at St. Jude Children's Research Hospital, where he oversees the Divisions of Experimental Hematology and Clinical Hematology.


Dr. Weiss’ research focuses on understanding the biology of blood cell development, particularly red blood cells. Since moving to St. Jude, his work has placed a greater emphasis on translational studies aimed at developing new treatments for hemoglobinopathies, particularly sickle disease and -thalassemia. Dr. Weiss has published over 130 original research papers in journals that include Blood, Journal of Clinical Investigation, Nature, Nature Genetics, Nature Medicine, Science Translational Medicine and Proceedings of the National Academy of Science. He has been funded continually by the National Institutes of Health (NIH) since 2002 and is a permanent member of the NIH study section, Molecular and Cellular Hematology. He is a member of The American Society for Clinical Investigation and The Association of American Physicians. Dr. Weiss’ mission as Hematology Chairman at St. Jude Children’s Research Hospital is to facilitate cutting edge basic, translational and clinical research, foster faculty development and promote outstanding clinical care for patients with non-malignant blood disorders.